Cargando…
Connexin 43-Based Therapeutics for Dermal Wound Healing
The most ubiquitous gap junction protein within the body, connexin 43 (Cx43), is a target of interest for modulating the dermal wound healing response. Observational studies found associations between Cx43 at the wound edge and poor healing response, and subsequent studies utilizing local knockdown...
Autores principales: | Montgomery, Jade, Ghatnekar, Gautam S., Grek, Christina L., Moyer, Kurtis E., Gourdie, Robert G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6032231/ https://www.ncbi.nlm.nih.gov/pubmed/29914066 http://dx.doi.org/10.3390/ijms19061778 |
Ejemplares similares
-
The Effect of a Connexin43-Based Peptide on the Healing of Chronic Venous Leg Ulcers: A Multicenter, Randomized Trial
por: Ghatnekar, Gautam S, et al.
Publicado: (2015) -
Impact of the Controlled Release of a Connexin 43 Peptide on Corneal Wound Closure in an STZ Model of Type I Diabetes
por: Moore, Keith, et al.
Publicado: (2014) -
Connexin 43 confers chemoresistance through activating PI3K
por: Pridham, Kevin J., et al.
Publicado: (2022) -
Evaluation of a connexin-based peptide for the treatment of age-related macular degeneration
por: Obert, Elisabeth, et al.
Publicado: (2022) -
Targeting connexin 43 with α–connexin carboxyl-terminal (ACT1) peptide enhances the activity of the targeted inhibitors, tamoxifen and lapatinib, in breast cancer: clinical implication for ACT1
por: Grek, Christina L, et al.
Publicado: (2015)